Mammalian target of rapamycin-independent S6K1 and 4E-BP1 phosphorylation during contraction in rat skeletal muscle.
about
Rapamycin reverses paraquat-induced acute lung injury in a rat model through inhibition of NFκB activationMolecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle.Alcohol impairs skeletal muscle protein synthesis and mTOR signaling in a time-dependent manner following electrically stimulated muscle contractionRictor negatively regulates high-affinity receptors for IgE-induced mast cell degranulation.Endurance exercise induces REDD1 expression and transiently decreases mTORC1 signaling in rat skeletal muscle.Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).Gerosuppression by pan-mTOR inhibitors.Rapamycin delays salivary gland atrophy following ductal ligation.Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat.Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells.Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) is an AMPK target participating in contraction-stimulated glucose uptake in skeletal muscle.Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.Increased Skeletal Muscle GLUT4 Expression in Obese Mice After Voluntary Wheel Running Exercise Is Posttranscriptional.Low dose of IGF-I increases cell size of skeletal muscle satellite cells via Akt/S6K signaling pathway.Relationship between exercise volume and muscle protein synthesis in a rat model of resistance exercise.A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators.The PI3K/AKT pathway in obesity and type 2 diabetes
P2860
Q28383433-EA5B0E3F-CEA3-4580-B0E9-417644E8618AQ30278688-714A042A-1452-4A6F-B4C0-CED756D0C9CFQ34519008-56FF0365-4A6B-487A-9BBD-2B7B30671F11Q34646844-E489CD67-76BF-47E1-9FC8-523433E99B35Q35094227-C80093AC-8CB1-454C-8EA9-615D2564B3E9Q36414149-78F7E10B-0306-4724-8528-64035F82A5AAQ37610218-61E8AD8C-1288-439B-ADF4-7FF745158D3AQ37680203-FB31E1FA-A1E4-43A4-ABB2-EE6C74FB88EEQ37704685-B028A8BF-D0A8-4A24-A690-0DC51A6DC764Q38713053-6BD659EA-255E-4ACE-8CF7-9EB495DB2B3EQ38863014-C2CC18BB-636C-4B9D-9E78-7EBB739918AFQ39117162-418C8BCD-7AEB-4203-94FF-24C9322BA46EQ41509271-2C6F6D48-84D4-4BA9-9C3B-39C8E69AC982Q41640112-948832AA-8C7A-4435-86DD-3E684822D4E0Q47390484-BEAD8EC2-AE2C-4494-8228-EE57B7DAE2A9Q50879152-99064B1E-EA76-4ED1-A0BB-9CEA77318422Q54365047-051719DD-40F7-418E-A555-2C816F0761F2Q58798256-F76CFABD-92E0-45FF-B02E-40FD5BCC1851
P2860
Mammalian target of rapamycin-independent S6K1 and 4E-BP1 phosphorylation during contraction in rat skeletal muscle.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Mammalian target of rapamycin- ...... action in rat skeletal muscle.
@en
Mammalian target of rapamycin- ...... action in rat skeletal muscle.
@nl
type
label
Mammalian target of rapamycin- ...... action in rat skeletal muscle.
@en
Mammalian target of rapamycin- ...... action in rat skeletal muscle.
@nl
prefLabel
Mammalian target of rapamycin- ...... action in rat skeletal muscle.
@en
Mammalian target of rapamycin- ...... action in rat skeletal muscle.
@nl
P50
P1433
P1476
Mammalian target of rapamycin- ...... action in rat skeletal muscle.
@en
P2093
Mark H Rider
P304
P356
10.1016/J.CELLSIG.2013.05.005
P577
2013-05-22T00:00:00Z